Monthly Archives: February 2016

Nanomedicine and Alzheimer’s disease

Alzheimer’s disease (AD) is a progressive and fatal neurological disorder causing cognitive and behavioural impairments. It affects over 35 million people worldwide and one in nine over the age of 69 alone [1]. Despite being first described in 1906 by Dr. Alois Alzheimer and considerable research efforts made, promising diagnosis and therapy approaches are very slow in progress.

Read more ›

Posted in Fellows Updates